Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 143 for “"coagulation factor"”.

  1. Coagulation factor V : pathology and biochemistry

    ROLE OF GLU96, ASP1O2 AND ASP111 IN FACTOR V Coagulation factor V activity is unmasked by thrombin-mediated excision of the central B domain resulting in a noncovalent heterodimer, factor Va. To understand the role of individual amino acids in maintaining the Ca²⁺-depenadent subunit interaction, …

    ubc Repository record for Coagulation factor V : pathology and biochemistry (opens in a new tab) Download PDF for Coagulation factor V : pathology and biochemistry (opens in a new tab)

  2. Molecular genetics of blood coagulation factor X

    … oligodeoxyribonucleotides coding for bovine factor X. Five positive colonies were identified, and plasmid DNA was isolated. Cleavage with restriction endonucleases showed that these plasmids (designated pBXl-5) contained inserts of 1530 bp, 770 bp, 700 bp, 1100 bp and 930 bp. DNA sequence …

    ubc Repository record for Molecular genetics of blood coagulation factor X (opens in a new tab) Download PDF for Molecular genetics of blood coagulation factor X (opens in a new tab)

  3. Role of Coagulation Factor XII in Atherosclerosis

    … innate and adaptive immune responses but also by factors of the blood coagulation system. In general hypercoagulability seems to increase the development and progression of experimental atherosclerosis in mice on an atherogenic background. In addition, the great majority of coagulation proteins …

    wurz-thes Repository record for Role of Coagulation Factor XII in Atherosclerosis (opens in a new tab)

  4. Coagulation Factor XIIIA: biochemical properties underlying physiological function.

    Factor XIIIA (FXIIIA) is a transglutaminase that crosslinks intra- and extracellular protein substrates. The oligomeric state of active FXIIIA remains controversial, and the present work commenced with addressing this issue. The results of size exclusion chromatography and analytical …

    louisville Repository record for Coagulation Factor XIIIA: biochemical properties underlying physiological function. (opens in a new tab)

  5. The roles of fibrinolysis in regulating coagulation factor XIII

    Coagulation factor XIII (FXIII) is a protransglutaminase enzyme that is activated at the end of the coagulation cascade. Activated FXIII (FXIIIa) stabilizes the blood clot from premature lysis by covalently crosslinking fibrin molecules to itself and to other anti-fibrinolytic proteins. Although …

    ubc Repository record for The roles of fibrinolysis in regulating coagulation factor XIII (opens in a new tab) Download PDF for The roles of fibrinolysis in regulating coagulation factor XIII (opens in a new tab)

  6. Studies on the procurement of blood coagulation factor VIII

    Coagulation factor VIII is needed for the treatment of patients with haemophilia. Requirements for factor VIII are important in determining the numbers of blood donations to be collected in Scotland. The final yield of factor VIII:C in products prepared from blood plasma, when prepared either in …

    edinburgh Repository record for Studies on the procurement of blood coagulation factor VIII (opens in a new tab)

  7. Bioengineering coagulation factor Xa substrate specificity into Streptomyces griseus trypsin

    … peptidase family, such as the vertebrate blood coagulation proteases. Dissection of this substrate specificity has been hindered by the complexity and physiological requirements of these proteases. In order to understand the mechanisms of extended substrate specificity, a bacterial trypsin-like …

    ubc Repository record for Bioengineering coagulation factor Xa substrate specificity into Streptomyces griseus trypsin (opens in a new tab) Download PDF for Bioengineering coagulation factor Xa substrate specificity into Streptomyces griseus trypsin (opens in a new tab)

  8. Structural Determinants for Heparin Binding in Human Coagulation Factor XI

    Coagulation factor XI plays an important role in the consolidation phase of blood coagulation. Previous studies from our laboratory and others have demonstrated that zymogen factor XI (FXI) binds to heparin with moderate (KD~110 nM) affinity via residues (K252, K253 and K255) located in the apple 3 …

    temple Repository record for Structural Determinants for Heparin Binding in Human Coagulation Factor XI (opens in a new tab)

  9. Production of recombinant human coagulation factor IX by transgenic pig

    … disorder caused by deficiency in functional coagulation factor IX (FIX) and about 28,000 patients worldwide in 2012. And current treatment is restricted to protein-replacement therapy, which required FIX concentrates for patients' life-time. Approximately 1 billion units FIX were consumed in …

    nebraska Repository record for Production of recombinant human coagulation factor IX by transgenic pig (opens in a new tab)

  10. Recombinant Engineering Strategies for the Production of Therapeutic Coagulation Factor Proteins

    Dysregulated coagulation is a common clinical condition secondary to one of numerous blood dyscrasias and can be restored by therapeutic intervention with agents rich in coagulation factor proteins such as whole blood, fresh frozen plasma, prothrombin complex concentrates, and single coagulation …

    umn Repository record for Recombinant Engineering Strategies for the Production of Therapeutic Coagulation Factor Proteins (opens in a new tab)

  11. Coagulation Factor XIIIA: Clinical and Biological Significance in Epithelial Ovarian Cancer

    … management. Abnormal hemostasis including hyper coagulation and increased fibrinolysis, as well as their clinical complications, are common in epithelial ovarian cancer. High levels of cross-linked fibrin degradation products (FDPs) have been found in epithelial ovarian cancer ascites. …

    whiterose Download PDF for Coagulation Factor XIIIA: Clinical and Biological Significance in Epithelial Ovarian Cancer (opens in a new tab)

  12. Novel function of coagulation factor Xa : conversion into a clot-dissolving cofactor

    … CONVERSION OF FXa INTO A CLOT-DISSOLVING COFACTOR. Factor Xa (FXa) is an essential blood clotting enzyme. A previously identified FXa derivative, Xa33/13, is generated by two distinct cleavages by the clot-dissolving (fibrinolytic) enzyme, plasmin. FXa is first converted to FXaβ by excision …

    ubc Repository record for Novel function of coagulation factor Xa : conversion into a clot-dissolving cofactor (opens in a new tab) Download PDF for Novel function of coagulation factor Xa : conversion into a clot-dissolving cofactor (opens in a new tab)

  13. Canadian Hemophilia Carriers Pregnancy Study: Coagulation Factor Levels and Postpartum Blood Loss

    … bleeding disorder caused by a deficiency in Factor VIII (FVIII) or Factor IX (FIX) that was previously thought to only affect men. Women are carriers for this disorder with recent studies showing that they may also be affected by hemophilia. In recent years, it has been consistently reported …

    queens Repository record for Canadian Hemophilia Carriers Pregnancy Study: Coagulation Factor Levels and Postpartum Blood Loss (opens in a new tab)

  14. Modulating the adhesive strength of blood clots by coagulation factor XIIIa-based technologies

    … the components and functions of the blood coagulation system has led to advances in the development of hemostatic materials. Blood clots form plugs over leaking vessels to stop bleeding. They need to be cohesive to resist fracture from the pressures of blood flow, and adhesive to stay …

    ubc Repository record for Modulating the adhesive strength of blood clots by coagulation factor XIIIa-based technologies (opens in a new tab) Download PDF for Modulating the adhesive strength of blood clots by coagulation factor XIIIa-based technologies (opens in a new tab)

  15. Generation of Long-Acting Coagulation Factor VIII for the Treatment of Haemophilia A

    … resulting from dysregulation of clotting factor VIII (FVIII) during haemostasis. Predominant mode of treatment is by replacement therapy with recombinant FVIII (rFVIII) on demand or as a prophylaxis (Berntorp et al., 2003, Gouider et al., 2015). While there are a number of rFVIII products …

    whiterose Download file for Generation of Long-Acting Coagulation Factor VIII for the Treatment of Haemophilia A (opens in a new tab)

  16. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

    … be an interaction between these peptides and the coagulation cascade, and currently, desmopressin, a drug analog of vasopressin, is a first line therapy for mild Hemophilia A, a common coagulopathy. In this work, interactions between vasopressin and oxytocin with a crucial member of the …

    concordia Download PDF for Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII (opens in a new tab)

  17. Effects of direct active-site anticoagulants on the fibrinolytic function of coagulation factor Xa

    … has found that cleavage products of clotting factor Xa (FXa) can enhance the generation of localized plasmin, the enzyme that degrades and solubilizes clots. This function is stabilized by blocking or chemically modifying the active site of FXa such that FXaβ, the first resulting fragment, …

    ubc Repository record for Effects of direct active-site anticoagulants on the fibrinolytic function of coagulation factor Xa (opens in a new tab) Download PDF for Effects of direct active-site anticoagulants on the fibrinolytic function of coagulation factor Xa (opens in a new tab)

  18. The influence of coagulation factor XIII-A V34L mutation on clot formation and stability

    Background: Coagulation factor XIII (FXIII) is a key enzyme in stabilising blood clots by cross-linking fibrin molecules together, amongst other effects on fibrinolysis and matrix protein stabilisation. The human FXIII-A V34L sequence variant leads to increased activation rates, forming clots with …

    whiterose Download PDF for The influence of coagulation factor XIII-A V34L mutation on clot formation and stability (opens in a new tab)

Page 1 of 8